The Next Biological Shock

COVID-19 was not a one-off. The healthcare industry has and will continue to face a spectrum of biological risks — from climate-driven disease emergence to a deliberate release of engineered pathogens — that could disrupt supply chains, undermine global R&D partnerships, and destabilize markets. This panel will unpack where the real vulnerabilities lie and how increased resilience and cross-border cooperation can protect both public health and the bottom line.

This session is part of the 44th Annual J.P. Morgan Healthcare Conference and open to all conference attendees. Join us at Convene, 40 O’Farrell Street, 5th Floor, in Pacific Hall.